Myelodysplastic Syndrome Clinical Trial

Clinical Trial Finder Myelodysplastic Syndrome Trials

A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants

See Locations Near You

Summary

The purpose of this study is to evaluate the efficacy and safety of Luspatercept when administered at the maximum approved dose in low-risk Myelodysplastic Syndrome participants who require red blood cell transfusions.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Participant had documented diagnosis of MDS according to World Health Organization (WHO) classification that met Revised International Prognostic Scoring System (IPSS-R) classification of very low-, low-, or intermediate-risk disease.
Participant has an Eastern Cooperative Oncology Group (ECOG) score of 0, 1, or 2.
Participant must have red blood cell transfusions according to study criteria.

Exclusion Criteria:

Participant has known clinically significant anemia due to iron, vitamin B12, or folate deficiencies, or autoimmune or hereditary hemolytic anemia, or gastrointestinal bleeding.
Participant has had a prior allogeneic or autologous stem cell transplant.
Participant has known history or diagnosis of AML.
Participant has uncontrolled hypertension.

Other protocol-defined inclusion/exclusion criteria apply

Study is for people with:

Myelodysplastic Syndrome

Phase:

Phase 3

Estimated Enrollment:

100

Study ID:

NCT06045689

Recruitment Status:

Recruiting

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 55 Locations for this study

See Locations Near You

Cancer and Blood Specialty Clinic
Los Alamitos California, 90720, United States More Info
Vu Phan, Site 0051
Contact
562-735-0602
Scripps Prebys Cancer Center
San Diego California, 92103, United States More Info
Marin Xavier, Site 0048
Contact
619-713-7900
Smilow Cancer Hospital at Yale New Haven
New Haven Connecticut, 06510, United States More Info
Amer Zeidan, Site 0033
Contact
203-737-7078
Sylvester Comprehensive Cancer Center-Miami
Miami Florida, 33136, United States More Info
Sangeetha Venugopal, Site 0042
Contact
888-888-8888
Florida Cancer Specialists - NORTH - SCRI - PPDS
Saint Petersburg Florida, 33705, United States More Info
Adewale Fawole, Site 0055
Contact
727-216-1143
Florida Cancer Specialists - SOUTH - SCRI - PPDS
Wellington Florida, 33414, United States More Info
Ivor Percent, Site 0056
Contact
239-274-9930
University of Kansas Medical Center
Kansas City Kansas, 66160, United States More Info
Jesus Gonzalez Lugo, Site 0020
Contact
913-945-6674
Mercy Health - Paducah Medical Oncology and Hematology
Paducah Kentucky, 42003, United States More Info
Wederson Claudino, Site 0025
Contact
000-000-0000
UMass Memorial Medical Center
Worcester Massachusetts, 01655, United States More Info
Jonathan Gerber, Site 0012
Contact
508-635-7093
Henry Ford Hospital
Detroit Michigan, 48202, United States More Info
Ahmad Mattour, Site 0011
Contact
313-433-1718
Dartmouth Hitchcock Medical Center
Lebanon New Hampshire, 03766, United States More Info
Christi Hayes, Site 0019
Contact
603-650-4628
Icahn School of Medicine at Mount Sinai
New York New York, 10029, United States More Info
Lewis Silverman, Site 0032
Contact
212-241-5520
James Cancer Hospital and Solove Research Institute - 460 W 10th Ave
Columbus Ohio, 43210, United States More Info
Uma Borate, Site 0006
Contact
503-418-2294
Oncology Associates of Oregon, P.C.
Eugene Oregon, 97401, United States More Info
Luke Fletcher, Site 0054
Contact
541-683-5001
West Penn Hospital
Pittsburgh Pennsylvania, 15224, United States More Info
Anna Koget, Site 0036
Contact
Texas Oncology - Amarillo
Amarillo Texas, 79106, United States More Info
Praveen Kumar Tumula, Site 0043
Contact
806-358-8654
North Houston Cancer Clinics - Huntsville
Huntsville Texas, 77340, United States More Info
Elham Abbasi-Hafshejani, Site 0022
Contact
936-439-5213
Wheeling Hospital Schiffler Cancer Center
Wheeling West Virginia, 26003, United States More Info
Bhavana Bhatnagar, Site 0031
Contact
614-293-7961
Froedtert and The Medical College of Wisconsin
Milwaukee Wisconsin, 53226, United States More Info
Ravi Narra, Site 0003
Contact
414-805-4600
Local Institution - 0016
Leuven Vlaams Brabant, 3000, Belgium More Info
Site 0016
Contact
Local Institution - 0008
Roeselare West-Vlaanderen, 8800, Belgium More Info
Site 0008
Contact
Local Institution - 0004
Praha 2 Praha, Hlavní Mesto, 128 2, Czechia More Info
Site 0004
Contact
Local Institution - 0023
Praha Praha, Hlavní Mesto, 128 2, Czechia More Info
Site 0023
Contact
Local Institution - 0041
Nice Alpes-Maritimes, 06202, France More Info
Site 0041
Contact
Local Institution - 0044
Tours Indre-et-Loire, 37044, France More Info
Site 0044
Contact
Local Institution - 0026
Angers , 49933, France More Info
Site 0026
Contact
Local Institution - 0007
Grenoble cedex 09 , 38 38, France More Info
Site 0007
Contact
Local Institution - 0046
Paris , 75475, France More Info
Site 0046
Contact
Local Institution - 0053
Pierre Benite , 69495, France More Info
Site 0053
Contact
Local Institution - 0001
Poitiers , 86021, France More Info
Site 0001
Contact
Local Institution - 0013
München Bayern, 81675, Germany More Info
Site 0013
Contact
Local Institution - 0040
Hannover Niedersachsen, 30161, Germany More Info
Site 0040
Contact
Local Institution - 0037
Gütersloh Nordrhein-Westfalen, 33332, Germany
Local Institution - 0009
Leipzig Sachsen, 04103, Germany More Info
Site 0009
Contact
Local Institution - 0021
Reggio Calabria Calabria, 89124, Italy More Info
Site 0021
Contact
Local Institution - 0050
Roma Lazio, 00133, Italy More Info
Site 0050
Contact
Local Institution - 0014
Novara Piemonte, 28100, Italy More Info
Site 0014
Contact
Local Institution - 0045
Torino Piemonte, 10128, Italy More Info
Site 0045
Contact
Local Institution - 0024
Firenze Toscana, 50139, Italy More Info
Site 0024
Contact
Local Institution - 0015
Pavia , 27100, Italy More Info
Site 0015
Contact
Local Institution - 0029
Rozzano (MI) , 20089, Italy More Info
Site 0029
Contact
Local Institution - 0002
Wroclaw Dolnoslaskie, 50-55, Poland More Info
Site 0002
Contact
Local Institution - 0030
Lublin Lubelskie, 20-08, Poland More Info
Site 0030
Contact
Local Institution - 0049
Lodz Lódzkie, 93-51, Poland More Info
Site 0049
Contact
Local Institution - 0010
Warszawa Mazowieckie, 02-17, Poland More Info
Site 0010
Contact
Local Institution - 0034
Katowice Slaskie, 40-51, Poland More Info
Site 0034
Contact
Local Institution - 0035
Wałbrzych , 58-30, Poland More Info
Site 0035
Contact
Auxilio Mutuo Cancer Center
San Juan , 00917, Puerto Rico More Info
Adelba Torres Lopez, Site 0047
Contact
7877582000
Local Institution - 0017
L'Hospitalet de Llobregat Barcelona, 08908, Spain More Info
Site 0017
Contact
Local Institution - 0005
Barcelona , 08035, Spain More Info
Site 0005
Contact
Local Institution - 0052
Barcelona , 08916, Spain More Info
Site 0052
Contact
Local Institution - 0039
Granada , 18014, Spain More Info
Site 0039
Contact
Local Institution - 0038
Madrid , 28006, Spain More Info
Site 0038
Contact
Local Institution - 0027
Ourense , 32005, Spain More Info
Site 0027
Contact
Local Institution - 0028
Salamanca , 37007, Spain More Info
Site 0028
Contact
Local Institution - 0018
Valencia , 46010, Spain More Info
Site 0018
Contact
Load More

How clear is this clinincal trial information?

Study is for people with:

Myelodysplastic Syndrome

Phase:

Phase 3

Estimated Enrollment:

100

Study ID:

NCT06045689

Recruitment Status:

Recruiting

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.